Abstract
The enzyme poly (ADP-ribose) polymerase (PARP) — also termed poly (ADP-ribose) synthetase (PARS) and poly (ADP-ribose) transferase (pPADPRT) — is an abundant nuclear protein present throughout the phylogenetic spectrum. The precise physiologic roles of PARP remain undefined; its traditional role as a DNA-repair enzyme has been questioned by recent studies. PARP plays diverse roles, participating in DNA repair, chromatin relaxation, cell differentiation, DNA replication, transcriptional regulation, control of cell cycle, p53 expression and apoptosis, and transformation [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
De Murcia G, Shall S (2000) From DNA Damage and Stress Signaling to Cell Death; Poly ADP-ribosylation Reactions. Oxford University Press, Oxford
Szabo C (2000) Cell Death: The Role of PARP. CRC Press, Boca Raton
Szabó C, Dawson VL (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19: 287–298
Liaudet L, Szabó E, Timashpolsky L, Virâg L, Cziraki A, Szabó C (2001) Localization of poly (ADP-ribose) polymerase (PARP) activation in a rat model of myocardial reperfusion injury: suppression of PARP activation and long-term morphological and functional improvement by 3-aminobenzamide. Br J Pharmacol 133: 1424–1430
Pieper AA, Walles T, Wei G, Clements EE, Verma A, Snyder SH (2000) Myocardial postischemic injury is reduced by polyADPribose polymerase-1 gene disruption. Mol Med 6: 271–282
Szabados E, Literati-Nagy P, Farkas B, Sumegi B (2000) BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADPribose) polymerase. Biochem Pharmacol 59: 937–945
Szabados E, Fischer GM, Toth K, Csete B, Nemeti B, Trombitas K (1999) Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Rad Biol Med 26: 309–317
Skuta G, Fischer GM, Janaky T, Kele Z, Szabo P, Tozser J (1999) Molecular mechanism of the short-term cardiotoxicity caused by 2’,3’-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions. Biochem Pharmacol 58: 1915–1925
Pieper AA, Blackshaw S, Clements EE, Brat DJ, Krug DK, White AJ (2000) Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc Natl Acad Sci USA 97: 1845–1850
Gilad E, Zingarelli B, Salzman AL, Szabo C (1997) Protection by inhibition of poly ( ADP-ribose) synthetase against oxidant injury in cardiac myoblasts in vitro. J Mol Cell Cardiol 29: 2585–2597
Szabó C, Zingarelli B, Salzman AL (1996) Peroxynitrite-mediated activation of poly-ADP ribosyl synthetase contributes to the vascular failure in shock. In: Okada K, Ogata H (ed) Shock: From Molecular and Cellular Level to Whole Body. Excerpta Medica International Congress Series 1102. Elsevier, Ansterdam, pp 3–14
Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman AL, Szabó C (1997) Inhibition of poly ( ADP ribose) synthetase protects against myocardial ischemia and reperfusion injury. Cardiovasc Res 36: 205–215
Thiemermann C, Bowes J, Myint FP, Vane JR (1997) Inhibition of the activity of poly ( ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 94: 679–683
Bowes J, Ruetten H, Martorana PA, Stockhausen H, Thiemermann C (1998) Reduction of myocardial reperfusion injury by an inhibitor of poly ( ADP-ribose) synthetase in the pig. Eur J Pharmacol 359: 143–150
Bowes J, Piper J, Thiemermann C (1998) Inhibitors of the activity of poly ( ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts. Br J Pharmacol 124: 1760–1766
Bowes J, McDonald MC, Piper J, Thiemermann C (1999) Inhibitors of poly ( ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress. Cardiovasc Res 41: 126–134
Docherty JC, Kuzio B, Silvester JA, Bowes J, Thiemermann C (1999) An inhibitor of poly ( ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart. Br J Pharmacol 127: 15181524
Janero DR, Hreniuk D, Sharif HM, Prout KC (1993) Hydroperoxide-induced oxidative stress alters pyridine nucleotide metabolism in neonatal heart muscle cells. Am J Physiol 264: C1401 - C1410
Szabados E, Fischer GM, Gallyas F Jr, Kispal G, Sumegi B (1999) Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart. Free Rad Biol Med 27: 1103–1113
Faro R, Toyoda Y, McCully J, et al (2002) Protective effect on regional myocardial function and infarct size induced by PJ34: a novel poly (ADP-ribose) synthetase inhibitor. Ann Thorac Surg (in press)
Zingarelli B, Salzman AL, Szabó C (1998) Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury. Circ Res 83: 85–94
Yang Z, Zingarelli B, Szabo C (2000) Effect of genetic disruption of poly ( ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock 13: 60–66
Grupp IL, Jackson TM, Hake P, Grupp G, Szabó C (1999) Protection against hypoxia-reoxygenation in the absence of poly ( ADP-ribose) synthetase in isolated working hearts. J Mol Cell Cardiol 31: 297–303
Liaudet L, Yang Z, Affar B, Szabó C (2001) Myocardial ischemic preconditioning in rodents is dependent on poly ( ADP-ribose) synthetase. Mol Med 7: 406–417
Garcia Soriano F, Virag L, Jagtap P, et al (2001) Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7: 108–113
Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabó C (2002) Novel phenanthridinone inhibitors of poly(ADP-ribose) synthetase: potent cytoprotective and anti-shock agents. Crit Care Med (in press)
Virag L, Salzman AL, Szabo C (1998) Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 161: 3753–3759
H Halmosi R, Berente Z, Osz E, Toth K, Literati-Nagy P, Sumegi B (2001) Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Mol Pharmacol 59: 1497–505
Szabó C, Wong HR, Bauer PI, Kirsten E, O’Connor M, Zingarelli B (1997) Regulation of components of the inflammatory response by 5-iodo-6-amino-1,2-benzopyrone, and inhibitor of poly ( ADP-ribose) synthetase and pleiotropic modifier of cellular signal pathways. Int J Oncol 10: 1093–1101
Roebuck KA, Rahman A, Lakshminarayanan V, Janakidevi K, Malik AB (1995) H202 and tumor necrosis factor-activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem 270: 18966–18974
Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18: 4446–4454
Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, Konopka G, Luo R, Wang ZQ (2000) Mis-regulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 97: 11274–11279
Szabó C, Lim LHK, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ (1997) Inhibition of poly ( ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med 186: 1041–1049
Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O’Connor MP (1998) Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 95: 3867–3872
Zingarelli B, Szabó C, Salzman AL (1999) Blockade of poly ( ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis, Gastroenterology 116: 335–345
Szabo C, Cuzzocrea S, Zingarelli B, O’Connor M, Salzman AL (1997) Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly ( ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100: 723–735
Sosulina LI, Sukhova GS, Chudnyi MN, Ashmarin IP (1999) The action of ADP ribose on the mechanical and bioelectrical activity of the frog. Ross Fiziol Zh Im I M Sechenova 85: 508–514
Freude B, Masters TN, Robicsek F, Fokin A, Kostin S, Zimmermann R (2000) Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 32: 197–208
De Boer RA, van Veldhuisen DJ, van Der Wijk J, Brouwer RM, de Jonge N, Cole GM (2000) Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Cardiac Failure 6: 330–337
Virag L, Scott GS, Cuzzocrea S, Marmer D, Salzman AL, Szabo C (1998) Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase ( PARS) activation. Immunology 94: 345–355
Herceg Z, Wang ZQ (1999) Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol Cell Biol 19: 5124–5133
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Szabó, C., Liaudet, L. (2002). Myocardial Ischemia-reperfusion Injury: Role of the Peroxynitrite-poly(ADP-ribose) Polymerase Pathway. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-5551-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5551-0_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-5553-4
Online ISBN: 978-1-4757-5551-0
eBook Packages: Springer Book Archive